SBC Medical Enters US Aesthetics Market with OrangeTwist Investment
OrangeTwist never sounded like a spa brand that wanted to whisper. It always felt like a signal flare. Bright, deliberate, impossible to miss. When SBC Medical Group Holdings decided to plant a flag in the United States aesthetics market, it did not knock quietly. It chose OrangeTwist, and that choice says more than any press release ever could.
Founded in 2015 by Dr. W. Grant Stevens and Clint Carnell, OrangeTwist grew the hard way. 24 locations across 6 states did not come from chasing trends. They came from understanding that aesthetics is not vanity, it is confidence economics. People do not buy treatments. They buy control over how they show up in the world, and OrangeTwist figured out how to package medical rigor inside a hospitality-driven experience that actually scales.
This investment marks SBC Medical Group Holdings’ first real move into the U.S. market, and it is not a toe in the water. It is a calculated step backed by decades of global operating discipline. SBC Medical Group Holdings runs hundreds of clinics, sees millions of patients annually, and understands process at a level most operators never reach. Pair that with OrangeTwist’s retail instinct and consumer fluency, and suddenly aesthetics looks less like a fragmented category and more like an actual platform.
Leadership matters when the stakes rise. Clint Carnell has been here before, turning HydraFacial from a strong product into a public market heavyweight. Dr. W. Grant Stevens brought medical credibility that money cannot buy. Today, Robert Settembro sits in the CEO seat, bringing multi-location operational muscle when complexity becomes the job. This is not a founding story frozen in time. It is an operating story that keeps evolving.
The structure matters too. A minority investment, preferred equity, collaboration baked in from day one. No chest pounding, no forced marriage. Just alignment around expansion, product development, and the quiet confidence that comes from knowing optionality beats bravado every time.
OrangeTwist does not sell invasive miracles. It sells consistency, safety, and repeatability in a market flooded with noise. SBC Medical Group Holdings does not chase headlines. It builds systems that survive scale. Together, they are not trying to convince the market they belong. They are behaving like people who already know where this category is headed and decided to arrive early.
In a sector obsessed with instant results, this deal is about patience, infrastructure, and long range thinking. A twist of orange, a global balance sheet, and a U.S. aesthetics market that just got a little more interesting without anyone needing to shout about it.